Dr Jones Limited Filleted accounts for Companies House (small and micro)

Dr Jones Limited Filleted accounts for Companies House (small and micro)


false false false false false false true false false true false false false false false false No description of principal activity 2019-01-01 Sage Accounts Production Advanced 2019 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 07283829 2019-01-01 2019-12-31 07283829 2019-12-31 07283829 2018-12-31 07283829 bus:Director1 2019-01-01 2019-12-31 07283829 core:ShareCapital 2019-12-31 07283829 core:ShareCapital 2018-12-31 07283829 bus:SmallEntities 2019-01-01 2019-12-31 07283829 bus:AuditExempt-NoAccountantsReport 2019-01-01 2019-12-31 07283829 bus:FullAccounts 2019-01-01 2019-12-31 07283829 bus:SmallCompaniesRegimeForAccounts 2019-01-01 2019-12-31 07283829 bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31
COMPANY REGISTRATION NUMBER: 07283829
Dr Jones Limited
Filleted Unaudited Financial Statements
31 December 2019
Dr Jones Limited
Financial Statements
Year ended 31 December 2019
Contents
Page
Statement of financial position
1
Notes to the financial statements
2
Dr Jones Limited
Statement of Financial Position
31 December 2019
2019
2018
Note
£
£
£
Current assets
Cash at bank and in hand
1
1
----
----
Net current assets
1
1
----
----
Total assets less current liabilities
1
1
----
----
Capital and reserves
Called up share capital
1
1
----
----
Shareholders funds
1
1
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 31 December 2019 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 June 2020 , and are signed on behalf of the board by:
Mr. M. Jones
Director
Company registration number: 07283829
Dr Jones Limited
Notes to the Financial Statements
Year ended 31 December 2019
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 26 Market Place, London, W1W 8AN, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4. Related party transactions
The company was under the control of Mr. M. Jones throughout the current period. Mr. M. Jones is the managing director and majority shareholder. No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 8.